Kathleen Laporte

Insider Reports History

Entity
Individual
Signature
/s/ Brian G. Atwood, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kathleen Laporte:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Homology Medicines, Inc. Director Stock Option (Right to Buy) 12.8K $171K $13.42 Mar 25, 2024 Direct
CERO THERAPEUTICS HOLDINGS, INC. Director Common Stock 966K $96.6K $0.10 Sep 25, 2024 By the Kathleen LaPorte Revocable Trust
Precipio, Inc. Director Common Stock 10.1K $67.5K $6.70 Apr 15, 2024 Direct
Homology Medicines, Inc. Director Common Stock 5.43K $3.1K $0.57 Mar 25, 2024 By the Kathleen LaPorte Revocable Trust
CERO THERAPEUTICS HOLDINGS, INC. Director Common Stock 5.83K $583 $0.10 Sep 25, 2024 Direct
CERO THERAPEUTICS HOLDINGS, INC. Director Series A Convertible Preferred Stock 0 $0 $1,000.00 Sep 25, 2024 Direct
CERO THERAPEUTICS HOLDINGS, INC. Director Stock Option (Right to Buy) 128K Dec 2, 2024 Direct
89bio, Inc. Director Stock Option (Right to Buy) 45.2K Feb 1, 2024 Direct
Bolt Biotherapeutics, Inc. Director Stock Option (Right to Buy) 22K Jun 12, 2024 Direct
Precipio, Inc. Director Stock Option (Right to Buy) 2K Aug 31, 2024 Direct
89bio, Inc. Director Common Stock 0 $11.53 Jul 17, 2023 Direct

Insider Reports Filed by Kathleen Laporte

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CERO CERO THERAPEUTICS HOLDINGS, INC. Dec 2, 2024 1 $0 4 Dec 4, 2024 Director
CERO CERO THERAPEUTICS HOLDINGS, INC. Sep 25, 2024 2 -$50K 4 Oct 2, 2024 Director
PRPO Precipio, Inc. Aug 31, 2024 20 $0 4 Sep 6, 2024 Director
PRPO Precipio, Inc. Jun 21, 2024 1 $0 4 Jun 25, 2024 Director
BOLT Bolt Biotherapeutics, Inc. Jun 12, 2024 1 $0 4 Jun 14, 2024 Director
PRPO Precipio, Inc. Apr 15, 2024 1 $64.9K 4 Apr 17, 2024 Director
CERO CERO THERAPEUTICS HOLDINGS, INC. Mar 25, 2024 1 $0 4 Mar 27, 2024 Director
QTTB Homology Medicines, Inc. Mar 25, 2024 1 $0 4 Mar 27, 2024 Director
QTTB Homology Medicines, Inc. Mar 25, 2024 0 $0 3 Mar 27, 2024 Director
CERO CERO THERAPEUTICS HOLDINGS, INC. Feb 14, 2024 1 $50K 4/A Feb 21, 2024 Director
CERO PHOENIX BIOTECH ACQUISITION CORP. Feb 14, 2024 2 $50K 4 Feb 16, 2024 Director
ETNB 89bio, Inc. Feb 1, 2024 1 $0 4 Feb 5, 2024 Director
PRPO Precipio, Inc. Sep 12, 2023 1 $0 4 Sep 14, 2023 Director
ETNB 89bio, Inc. Jul 17, 2023 3 -$202K 4 Jul 18, 2023 Director
BOLT Bolt Biotherapeutics, Inc. Jun 12, 2023 1 $0 4 Jun 14, 2023 Director
ETNB 89bio, Inc. Feb 9, 2023 1 $0 4 Feb 13, 2023 Director
PRPO Precipio, Inc. Jan 6, 2023 1 $0 4 Jan 10, 2023 Director
BOLT Bolt Biotherapeutics, Inc. Dec 14, 2022 1 $0 4 Dec 16, 2022 Director
BOLT Bolt Biotherapeutics, Inc. Jun 10, 2022 1 $0 4 Jun 10, 2022 Director
ETNB 89bio, Inc. May 16, 2022 1 $0 4 May 18, 2022 Director
BOLT Bolt Biotherapeutics, Inc. Mar 24, 2022 1 $0 4 Mar 28, 2022 Director
PRPO Precipio, Inc. Jan 11, 2022 1 $0 4 Jan 13, 2022 Director
ETNB 89bio, Inc. Nov 1, 2021 1 $0 4 Nov 3, 2021 Director
ETNB 89bio, Inc. Nov 1, 2021 0 $0 3 Nov 3, 2021 Director
PBAX PHOENIX BIOTECH ACQUISITION CORP. Oct 8, 2021 1 $0 4 Oct 12, 2021 Director
PBAX PHOENIX BIOTECH ACQUISITION CORP. Oct 5, 2021 0 $0 3 Oct 5, 2021 Director
PRPO Precipio, Inc. Aug 3, 2021 1 $0 4 Aug 5, 2021 Director